VC Deals Analysis: Variety In Volume, But Lackluster Value In April

08 May 2017

It would have been difficult to beat March's unusual bumper harvest, which benefitted from Grail's near-$1bn round, but venture fundraising efforts in April were stymied by the absence of deals beyond the $50m mark.

[Editors' note: For more details about VC deals in 2017 and previous years, go to Medtech Insight's VC deal tracker: https://medtech.pharmamedtechbi.com/datasets/vc-funding]

Deal volume bounced back in April after a two-month lag, with 26 transactions of $1m-and-over recorded by Medtech Insight's VC...